Kelly Jared
Chief Executive Officer
PurchaseAlert
- Shares
- 5,050
- Price
- $0.96
- Value
- $4,848
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•40 filings
ONCY
ONCOLYTICS BIOTECH INC
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 4 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$362,615
10 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
14
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
4 executive purchases found
Get ONCY insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ONCY overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
28
Raw transactions
Everything returned by the filing
14
Voluntary view
P/S trades after deterministic checks
14
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 145,000
- Price
- $0.00
- Footnotes
- 2
The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Parsons James T.
Director
PurchaseAlert
- Shares
- 10,000
- Price
- $1.03
- Value
- $10,300
Seizinger Bernd R.
Director
PurchaseAlert
- Shares
- 40,000
- Price
- $0.85
- Value
- $33,864
Pisano Wayne
Director
PurchaseAlert
- Shares
- 30,000
- Price
- $0.84
- Value
- $25,338
Look Kirk
Chief Financial Officer
PurchaseAlert
- Shares
- 12,000
- Price
- $0.84
- Value
- $10,104
Kelly Jared
Chief Executive Officer
PurchaseAlert
- Shares
- 29,500
- Price
- $0.84
- Value
- $24,839
Heineman Thomas Charles
Chief Medical Officer
PurchaseAlert
- Shares
- 12,132
- Price
- $0.83
- Value
- $10,033
Hagerman Allison
VP, Product Development
PurchaseAlert
- Shares
- 10,000
- Price
- $0.83
- Value
- $8,298
Brown Deborah Margaret
Director
PurchaseAlert
- Shares
- 25,000
- Price
- $0.85
- Value
- $21,240
Andrews Patricia S
Director
PurchaseAlert
- Shares
- 35,400
- Price
- $0.86
- Value
- $30,292
Seizinger Bernd R.
Director
PurchaseAlert
- Shares
- 60,000
- Price
- $0.83
- Value
- $49,590
Kelly Jared
Chief Executive Officer
PurchaseAlert
- Shares
- 5,600
- Price
- $0.84
- Value
- $4,682
Aromando Andrew
Chief Business Officer
PurchaseAlert
- Shares
- 29,600
- Price
- $0.86
- Value
- $25,418
Seizinger Bernd R.
Director
PurchaseAlert
- Shares
- 100,000
- Price
- $1.04
- Value
- $103,770
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Kelly Jared Chief Executive Officer | Purchase | 5,050 | $0.96 | $4,848 | |
| Mar 11, 2026 | Parsons James T. Director | Purchase | 10,000 | $1.03 | $10,300 | |
| Feb 12, 2026 | Seizinger Bernd R. Director | Purchase | 40,000 | $0.85 | $33,864 | |
| Feb 12, 2026 | Pisano Wayne Director | Purchase | 30,000 | $0.84 | $25,338 | |
| Feb 12, 2026 | Look Kirk Chief Financial Officer | Purchase | 12,000 | $0.84 | $10,104 | |
| Feb 12, 2026 | Kelly Jared Chief Executive Officer | Purchase | 29,500 | $0.84 | $24,839 | |
| Feb 12, 2026 | Heineman Thomas Charles Chief Medical Officer | Purchase | 12,132 | $0.83 | $10,033 | |
| Feb 12, 2026 | Hagerman Allison VP, Product Development | Purchase | 10,000 | $0.83 | $8,298 | |
| Feb 12, 2026 | Brown Deborah Margaret Director | Purchase | 25,000 | $0.85 | $21,240 | |
| Feb 12, 2026 | Andrews Patricia S Director | Purchase | 35,400 | $0.86 | $30,292 | |
| Feb 11, 2026 | Seizinger Bernd R. Director | Purchase | 60,000 | $0.83 | $49,590 | |
| Feb 11, 2026 | Kelly Jared Chief Executive Officer | Purchase | 5,600 | $0.84 | $4,682 | |
| Feb 11, 2026 | Aromando Andrew Chief Business Officer | Purchase | 29,600 | $0.86 | $25,418 | |
| Jan 16, 2026 | Seizinger Bernd R. Director | Purchase | 100,000 | $1.04 | $103,770 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.